Rapidly progressive glomerulonephritis historical perspective

Jump to navigation Jump to search

Rapidly progressive glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rapidly progressive glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray Findings

CT-scan Findings

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rapidly progressive glomerulonephritis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rapidly progressive glomerulonephritis historical perspective

CDC on Rapidly progressive glomerulonephritis historical perspective

Rapidly progressive glomerulonephritis historical perspective in the news

Blogs on Rapidly progressive glomerulonephritis historical perspective

Directions to Hospitals Treating Rapidly progressive glomerulonephritis

Risk calculators and risk factors for Rapidly progressive glomerulonephritis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jogeet Singh Sekhon, M.D. [2]

Overview


In 1958 Stanton and Tait from Australia studied these case reports and then named the findings as Goodpasture syndrome. They gave the anti GBM antibodies classification and discovered RPGN in these cases.In 1960s, electron microscopy and immunofluorescence helped to learn RPNG on immunological level.

Historical perspective

  • Ernst Goodpasture made case reports about glomerulnophritis and pulmonary haemorrhages in 1919[1].
  • Stanton and Tait from Australia studied these case reports and then named the findings as Goodpasture syndrome in 1958.
  • They gave the anti GBM antibodies classification and discovered RPGN in these cases.
  • In 1960s, electron microscopy and immunofluorescence helped to learn RPNG on immunological level.

References

  1. McAdoo SP, Pusey CD (2017). "Anti-Glomerular Basement Membrane Disease". Clin J Am Soc Nephrol. 12 (7): 1162–1172. doi:10.2215/CJN.01380217. PMC 5498345. PMID 28515156.